TP53 and B-cell chronic lymphocytic leukemia: Finally, the CLL-IPI score26,27 integrates genetic factors (IGHV mutation status, del(17p)/TP53 mutation), clinical stage, age, and beta-2 microglobulin for prognostic assessment (Table 2).